Actively Recruiting
The Effect of Dexmedetomidine on Agitation During Weaning From Mechanical Ventilation
Led by Sohag University · Updated on 2025-07-15
62
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the effect of dexmedetomidine on the level of agitation during the weaning process from mechanical ventilation in critically ill patients.
CONDITIONS
Official Title
The Effect of Dexmedetomidine on Agitation During Weaning From Mechanical Ventilation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult ICU patients 18 years or older
- On mechanical ventilation for at least 24 hours
- Clinically ready for weaning from mechanical ventilation
- Agitation score RASS of +1 or higher during spontaneous breathing trial
- Intubated for at least 4 days and up to 2 weeks
You will not qualify if you...
- Known hypersensitivity to dexmedetomidine
- Hemodynamic instability with heart rate below 50 beats per minute or mean arterial pressure below 60 mmHg
- Neurological impairment affecting consciousness level
- Pregnancy or currently breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sohag University Hospital
Sohag, Egypt
Actively Recruiting
Research Team
D
Dalia A Hussein, Resident
CONTACT
A
Al-haddad A Mousa, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here